These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 7807021)

  • 1. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
    Gärdby E; Lycke NY
    Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
    J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
    Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
    Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
    Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
    J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant.
    Wilson AD; Bailey M; Williams NA; Stokes CR
    Eur J Immunol; 1991 Oct; 21(10):2333-9. PubMed ID: 1833201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.
    Okahashi N; Yamamoto M; Vancott JL; Chatfield SN; Roberts M; Bluethmann H; Hiroi T; Kiyono H; McGhee JR
    Infect Immun; 1996 May; 64(5):1516-25. PubMed ID: 8613355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional dichotomy of interleukin-4 and -5 regulation of senescent B cell responses specific for cholera toxin in Peyer's patches, lamina propria, and mesenteric lymph nodes.
    Haq JA; Szewczuk MR
    Reg Immunol; 1993; 5(1):60-7. PubMed ID: 8347471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
    Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera toxin adjuvant greatly promotes antigen priming of T cells.
    Hörnquist E; Lycke N
    Eur J Immunol; 1993 Sep; 23(9):2136-43. PubMed ID: 8370397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
    Chen KS; Strober W
    Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
    Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
    J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice.
    Gärdby E; Lane P; Lycke NY
    J Immunol; 1998 Jul; 161(1):49-59. PubMed ID: 9647206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
    Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
    Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
    Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.